Project Grant R35GM163528
- Federal Grant Award Summary Columbia University's Health Sciences Division received a $446,876 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on genome organization and long noncoding RNA (lncRNA) regulation of gene expression. The award, initiated February 6, 2026, with completion targeted for January 31, 2031, supports investigator-initiated basic research...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $408,367 to Massachusetts General Hospital, effective August 15, 2025 through June 30, 2029. This Project Grant supports fundamental research investigating the molecular mechanisms of heterochromatin formation in eukaryotic cells, with particular focus on histone H3 lysine 9 methylation (H3K9me) and its role in...
- Federal Project Grant Award Summary The University of Colorado received a $238,819 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2028. The award funds fundamental research investigating the regulation of zinc-dependent lysosome morphological restructuring, zinc trafficking, and low zinc homeostasis mechanisms across Caenorhabditis elegans...
- Federal Grant Award Summary The Mount Desert Island Biological Laboratory received a $464,750 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 15, 2026, with completion targeted for January 31, 2031. This award supports fundamental research exploring tissue-specific mechanisms and requirements for nucleolin organization in living organisms. The research utilizes Caenorhabditis...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $484,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on February 15, 2026, with completion targeted for December 31, 2030. The award funds a five-year research initiative titled "Visualization of Native Chromatin-Associated Complexes to Elucidate Chromatin Regulatory Mechanisms." The project...
- Federal Project Grant Award Summary The University of Southern California received a $451,259 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2029. This award supports fundamental research investigating heterochromatin repair mechanisms from a chromatin perspective. The project will deliver scientific discoveries addressing how chromatin...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $275,100 to The Regents of the University of Colorado (University of Colorado-Denver) under the Biomedical Research and Research Training program (CFDA 93.859). The award, effective June 1, 2025, through May 31, 2030, supports fundamental biomedical research investigating functional protein disorder in intracellular transport mechanisms within human cells. The research focuses on...
- Federal Grant Award Summary The University of Minnesota's Regents, through its Office of Sponsored Projects Administration, received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. The award supports fundamental basic science research investigating the impacts of copy number variation on gene regulatory networks and...
- Federal Grant Award Summary The University of Colorado-Denver received a $390,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award funds fundamental biomedical research investigating the molecular function and substrate specificity of palmitoyltransferases (PATs)—a family of 24 mammalian enzymes that catalyze post-translational...
- Federal Project Grant Award Summary The University of Chicago received a $480,083 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 15, 2026 through January 31, 2031. This fundamental research project focuses on understanding how embryonic developmental mechanisms evolve across fly species, with particular emphasis on the natural variation of anterior-posterior axis...
The Klocko Laboratory at the University of Colorado Colorado Springs (UCCS) received a Project Grant of $325,938 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through May 31, 2031. The award funds fundamental research into genome organization and function in fungi, specifically utilizing Neurospora crassa as a model organism to understand how eukaryotic genomes are precisely organized within cell nuclei. The research investigates the mechanisms underlying the segregation and formation of heterochromatin and euchromatin, epigenetic factors affecting genome organization, and how chromatin composition impacts gene expression and genome function. This basic research initiative directly addresses critical gaps in understanding genome organization applicable to human disease, particularly how genome disorder can lead to aberrant gene expression and oncogenic tumor formation. By employing Neurospora crassa—a genetically tractable fungal model with epigenetic regulation and chromatin properties similar to humans—the laboratory can conduct cost-efficient, high-resolution genomic studies while also advancing understanding of chromatin properties in fungal pathogens affecting human health. The five-year project supports investigator-initiated biomedical research consistent with NIGMS's mission to establish the foundation for advances in disease diagnosis, treatment, and prevention through enhanced understanding of fundamental biological processes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $325.9k | 4/30/26 |